Portfolio company
NETRI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
NETRI develops organ-on-chip devices and AI algorithms for pharmaceutical and cosmetic companies to predict drug toxicity and efficacy using human cell models.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VitrofluidiX
VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.
Quris
Quris develops a platform using organ-on-a-chip technology and artificial intelligence to predict the safety and efficacy of drug candidates for pharmaceutical companies.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
PIXL BIO
This company develops human iPSC-derived cell models and AI-powered phenomics software for pharmaceutical firms to conduct predictive drug discovery and safety assessments.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Tissue Dynamics
This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.
